Phase II study of neoadjuvant chemotherapy with fluorouracil, leucovorin, oxaliplatin and docetaxel for resectable esophageal squamous cell carcinoma. First-line (1L) tislelizumab (TIS) plus ...

When we need to analyze a moderately complex circuit and we are thrown back onto our own resources because we don’t have access to SPICE or some other software aid ...

In their 2014 editorial, Tran et al 1 provocatively asked “who will listen?” in reference to evidence supporting adjuvant radiation (aRT) for the management of pathologically node-positive (pN1) ...